According to official sources, India's first indigenously developed quadrivalent Human Papillomavirus Vaccine (qHPV) will be launched tomorrow.
New Delhi: India put one step forward towards cervical cancer as all women are at risk for cervical cancer. It occurs most often in women over age 30. India is about to get the first indigenous vaccine against cervical cancer. The country’s first indigenous vaccine will be launched by Serum Institute of India and Department of Biotechnology on September 1. According to official sources, India’s first indigenously developed quadrivalent Human Papillomavirus Vaccine (qHPV) will be launched tomorrow.
According to the information, Union Minister of State (Independent Charge) Science and Technology Jitendra Singh will launch the vaccine on Thursday. Dr NK Arora, Chairperson, COVID Working Group, National Technical Advisory Group on Immunization (NTAGI), said that launching a Made-in-India vaccine is an exciting experience. Glad that our daughters will be able to receive this much awaited vaccine.
According to information received from sources, the vaccine can be given to girls between the ages of nine and 14. A source with knowledge of this vaccine said, “Initially these vaccines will be given only to girls, but later it will be given to boys also.” The price will not be a major constraint as the vaccine is being prepared in the country.
“It is very effective and prevents cervical cancer because, 85% to 90% of cases, cervical cancer is because of this particular virus and this vaccine is against those viruses. So, if we give it to our young children and daughters, they are protected from the infection and consequently probably 30 years later, cancer does not occur,” Dr Arora further explained.
“There was a shortage in the global market. Now Indian vaccine has come. So, we will be able to take care of our requirements within our made-in-India vaccine,” he said.
According to the World Health Organization (WHO) data, 41, 91,000 women have died due to cervical cancer in India since 2019.